Meredith signs up to craft custom content for point-of-care network's pharma clients

Waiting room
Interest in point-of-care marketing is increasing as pharma looks to focus on patients and physicians in decision-making mode. (FierceHealthcare)

Content is king, as the saying goes, and it’s especially important in pharma and healthcare. That’s why point-of-care agency Mesmerize has struck a deal with Meredith, the publisher of stalwart magazines such as Better Homes & Gardens, Real Simple and Diabetic Living.

Meredith Health Solutions, the publisher’s custom pharma and health content division, will supply Mesmerize with content—both repurposed from its magazines and original work for specific projects—to use in its in-office projects with pharma companies.

The deal will also include custom magazines built around a single condition, such as diabetes, heart health or living with HIV. The Mesmerize network includes 60,000 medical locations in the U.S.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

The partnership just launched this month, but one effort already up and running is a diabetes program for Merck & Co. In-office wallboards feature Meredith content discussing issues like eating and exercise to manage diabetes, along with a small ad from Merck, said Mesmerize president Craig Mait.

“We’ve learned it’s important to have a content partner along with any advertising that goes into point of care. Seeing a giant ad for a drug on your wall is very different than seeing a tasteful ad intermixed with relevant educational content,” he said in an interview.

While the content and advertising mix in Mesmerize’s network is static, it’s working to add digital and video back in—it sold off its digital network several years ago—with plans to launch a new digital network in the third quarter with more Meredith content.

RELATED: Outcome's image rehab rolls on with Nielsen deal for first-ever POC audience tallies

Meredith isn’t alone in its healthcare custom content drive; Condé Nast, publisher of well-known titles including Self, Vanity Fair and Glamour, launched Condé Nast Pharma two years ago to provide custom content for pharma clients.

Point-of-care marketing is also experiencing a surge in interest as traditional and digital media channels bog down with ads and marketers look to reach patients in decision-making mode. ZS Associates estimated POC will reach 70% of doctors’ offices by 2020, up from 30% in 2014. Sales are expected to reach almost $850 million by 2020, ZS predicted.

Suggested Articles

Eli Lilly’s Taltz has followed Novartis rival Cosentyx into all its therapy areas. But this time, Lilly wants to be first.

More signs of trouble for Bayer and J&J's Xarelto? As prescriptions flag, the drugmakers blame stepped-up discounts for its U.S. sales woes.

On the cusp of FDA approval for its landmark SMA gene therapy Zolgensma, Novartis is investigating an infant's death in a European trial.